Results 161 to 170 of about 54,702 (261)

Proton pump inhibitor exposure modulates functional and transcriptional responses in <i>Lactobacillus acidophilus</i>: a comprehensive computational and experimental insights. [PDF]

Front Cell Infect Microbiol
Naorem RS, Dutta K, Bora SS, Teli AB.
europepmc   +1 more source

Lactic acid bacteria and endogenous ethanol mediate proton pump inhibitor-associated MASLD: a multicohort cross-sectional mediation analysis. [PDF]

Gut Microbes
Davids M, Herrema H, K Groen A, Galenkamp H, Zwinderman A, Palmu J, Havulinna A, Niiranen T, Knight R, Acherman Y, Franken R, Verheij J, Dukas M, Dutch Liver Pathology Panel, Bajaj J, Llorente C, Schnabl B, Nieuwdorp M, Meijnikman A.   +18 more
europepmc   +1 more source

Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study. [PDF]

Pharmacol Res Perspect
Dinesh D, Morgan XC, Kim H, Scott TM, Garelnabi M, Lee JS, Mangano KM, Nguyen LH, Huttenhower C, Tucker KL, Palacios N.   +10 more
europepmc   +1 more source

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

Animal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali, Delower Hossain, Ridwan Olamilekan Adesola, Anum Hanif, Shamsaldeen Ibrahim Saeed, Muhammad Abdul Mannan, Anoar Jamai Masroure, Kazi Estieque Alam, Md Kamal Hossain, Sabiha Zarin Tasnim Bristi, Md Jisan Ahmed   +10 more
wiley   +1 more source

Association of Proton Pump Inhibitor Use with Cancer in Patients Undergoing Maintenance Hemodialysis: A Population-Based Cohort Study. [PDF]

J Clin Med
Kang SH, Park SY, Lim YJ, Kim BY, Choi JY, Do JY.   +5 more
europepmc   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source

Proton Pump Inhibitor-Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy. [PDF]

DEN Open
Ikeda R, Kaneko H, Sato H, Matsuoka Y, Hamaguchi T, Ikeda A, Goda Y, Sue S, Irie K, Maeda S.   +9 more
europepmc   +1 more source

Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real‐world data from the ILD‐PRO Registry

Arthritis &Rheumatology, Accepted Article.
Objective We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease‐associated progressive pulmonary fibrosis (SARD‐PPF) and evaluated whether outcomes differed by SARD subtype. Methods The ILD‐PRO Registry is a prospective multicenter US registry of patients with PPF.
Sonali J Bracken, Jeremy M Weber, Megan L Neely, Aparna C Swaminathan, Scott M Palmer, Erin M Wilfong, Ann D Chauffe, Elizabeth R Volkmann   +7 more
wiley   +1 more source

Profound Hypomagnesemia Due to Proton Pump Inhibitor Use-Associated Wernicke's Encephalopathy: A Case Report on Excitotoxicity. [PDF]

Cureus
Delforge B, Volon B, Laurent Y, Steinier C.   +3 more
europepmc   +1 more source

Real-World Observational Clinical Study Assessing the Effectiveness and Safety of Vonoprazan-Based Dual Therapy Versus Proton Pump Inhibitor-Based Triple Therapy for <i>Helicobacter pylori</i> Eradication. [PDF]

Gastroenterology Res
Bandyopadhyay S, Panchal G, Khalse M, Patel K.   +3 more
europepmc   +1 more source